| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0038 | 1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |